(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. MAPK signaling is required for transfating. Right panels show embryo
whole mounts immunostained with mAb 6a9 and examined by confocal microscopy.
The remaining panels show living embryos viewed with differential interference
optics, except H and K, which are in situ hybridizations. (A-C) Control
embryos at the late gastrula stage. 65-70 PMCs are arranged in a subequatorial
ring pattern (arrow). (D-F) Embryos treated with 6 µM U0126 from the
2-cell stage. Arrows in E indicate locations adjacent to ectodermal
thickenings where ventrolateral clusters of PMCs normally form. Arrow in F
indicates one of two 6a9-positive cells that formed in this embryo, which was
treated with U0126 until sibling controls reached the prism stage.
(G-I) Control PMC-deficient embryos (not treated with U0126).
Transfating is indicated by skeleton formation (G; 24 hours after surgery),
Lvalx1 mRNA expression (H; 8 hours after surgery), and 6a9
immunostaining (I; 12 hours after surgery). (J-L) PMC-deficient embryos
transferred to 6 µM U0126 immediately after surgery (J,K and L show embryos
24, 8 and 24 hours after surgery, respectively).